Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter‐structure in the aggregation response of human neutrophils

Human neutrophils aggregate after stimulation with various stimuli; this response is completely absent in neutrophils from patients with leukocyte adhesion defiency (LAD). To investigate the cellular requirements of this process a method was used in which neutrophils are separately loaded with hydro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of immunology 1990-03, Vol.20 (3), p.501-508
Hauptverfasser: Kuypers, Taco W., Koenderman, Leo, Weening, Ron S., Verhoeven, Arthur J., Roos, Dirk
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 508
container_issue 3
container_start_page 501
container_title European journal of immunology
container_volume 20
creator Kuypers, Taco W.
Koenderman, Leo
Weening, Ron S.
Verhoeven, Arthur J.
Roos, Dirk
description Human neutrophils aggregate after stimulation with various stimuli; this response is completely absent in neutrophils from patients with leukocyte adhesion defiency (LAD). To investigate the cellular requirements of this process a method was used in which neutrophils are separately loaded with hydroethidine (HE) and sulfofluorescein (SFDA), to give them either red fluorescence or green fluorescence. After mixing HE‐ and SFDA‐labeled cells in a ratio of 1 : 1, the number of double‐colored aggregates formed after activation was determined by analysis on a fluorescence‐activated cell sorter. In this way, essential information is obtained when cells of different origin are used. The formation of aggregates between neutrophils of an LAD patient and control neutrophils was thus quantified. Because neutrophil aggregation is dependent mostly on the presence of complement receptor type 3 (CR3), which is not present on LAD neutrophils, this result revealed the presence of a counter‐structure for CR3 on LAD neutrophils (and hence on normal human neutrophils). In addition to the presence of these proteins on the cell surface, aggregation required continuous cell triggering as indicated by the transient aggregation induced by short‐term activation of protein kinase C. This phenomenon was substantiated by the fact that energy depletion caused profound disaggregation. The present study reveals that neutrophil aggregation is a well‐controlled process, which needs constant activation of CR3 for a stable interaction with a constitutively expressed counter‐structure.
doi_str_mv 10.1002/eji.1830200307
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79694495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>15811429</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4007-803380097853792ac337b6d46565215903010ffe50984b66fcd01beeac7d3ce03</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi1EVZbClRuSD4hbtuPYSewjWhUoqsSlPUeOd7LrKrGD7VDtrY_Ac_BYPAmOdlW49TSH-eafmf8n5B2DNQMoL_HerpnkUAJwaF6QFatKVggm2EuyAmCiKJWEV-R1jPcAoOpKnZPzkkloSrEivzfeJetmP0dqcBioNsn-1Ml6R22kDg3GqMOB9j7QmHQ3ILUuYVi4zPieGj9OA47oEg0Zn1Im02FCyumDTXtqU5b28zL05_FXTGE2aQ6LDE17pHq3C7g7bgwYJ-8iLrL7edQuHzCn4Ke9HeIbctbrIeLbU70gd5-vbjdfi5vvX643n24KIwCaQgLnMj_ayIo3qtSG86art6Ku6uxMpbJNDPoeK1BSdHXdmy2wDlGbZssNAr8gH4-6U_A_ZoypHW1cvNEOs01to2olhKqeBVklGROlyuD6CJrgYwzYt1OwY3a1ZdAuKbY5xfZfinng_Ul57kbcPuGn2HL_w6mvo9FDH7QzNj5htRR1IxdMHbEHO-DhmaXt1bfr_074Cxs3ufU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15811429</pqid></control><display><type>article</type><title>Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter‐structure in the aggregation response of human neutrophils</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Kuypers, Taco W. ; Koenderman, Leo ; Weening, Ron S. ; Verhoeven, Arthur J. ; Roos, Dirk</creator><creatorcontrib>Kuypers, Taco W. ; Koenderman, Leo ; Weening, Ron S. ; Verhoeven, Arthur J. ; Roos, Dirk</creatorcontrib><description>Human neutrophils aggregate after stimulation with various stimuli; this response is completely absent in neutrophils from patients with leukocyte adhesion defiency (LAD). To investigate the cellular requirements of this process a method was used in which neutrophils are separately loaded with hydroethidine (HE) and sulfofluorescein (SFDA), to give them either red fluorescence or green fluorescence. After mixing HE‐ and SFDA‐labeled cells in a ratio of 1 : 1, the number of double‐colored aggregates formed after activation was determined by analysis on a fluorescence‐activated cell sorter. In this way, essential information is obtained when cells of different origin are used. The formation of aggregates between neutrophils of an LAD patient and control neutrophils was thus quantified. Because neutrophil aggregation is dependent mostly on the presence of complement receptor type 3 (CR3), which is not present on LAD neutrophils, this result revealed the presence of a counter‐structure for CR3 on LAD neutrophils (and hence on normal human neutrophils). In addition to the presence of these proteins on the cell surface, aggregation required continuous cell triggering as indicated by the transient aggregation induced by short‐term activation of protein kinase C. This phenomenon was substantiated by the fact that energy depletion caused profound disaggregation. The present study reveals that neutrophil aggregation is a well‐controlled process, which needs constant activation of CR3 for a stable interaction with a constitutively expressed counter‐structure.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.1830200307</identifier><identifier>PMID: 2180724</identifier><identifier>CODEN: EJIMAF</identifier><language>eng</language><publisher>Weinheim: WILEY‐VCH Verlag GmbH</publisher><subject>Adenosine Triphosphate - metabolism ; Antibodies, Monoclonal ; Biological and medical sciences ; Cations - pharmacology ; Cell Adhesion Molecules - physiology ; Cell Aggregation ; Energy Metabolism ; Flow Cytometry ; Fundamental and applied biological sciences. Psychology ; Humans ; In Vitro Techniques ; Inflammation ; Iodoacetates - pharmacology ; Iodoacetic Acid ; Macrophage-1 Antigen ; Molecular and cellular biology ; Nephelometry and Turbidimetry ; Neutrophils - physiology ; Receptors, Complement - physiology</subject><ispartof>European journal of immunology, 1990-03, Vol.20 (3), p.501-508</ispartof><rights>Copyright © 1990 Wiley‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>1990 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4007-803380097853792ac337b6d46565215903010ffe50984b66fcd01beeac7d3ce03</citedby><cites>FETCH-LOGICAL-c4007-803380097853792ac337b6d46565215903010ffe50984b66fcd01beeac7d3ce03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Feji.1830200307$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Feji.1830200307$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6846784$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2180724$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kuypers, Taco W.</creatorcontrib><creatorcontrib>Koenderman, Leo</creatorcontrib><creatorcontrib>Weening, Ron S.</creatorcontrib><creatorcontrib>Verhoeven, Arthur J.</creatorcontrib><creatorcontrib>Roos, Dirk</creatorcontrib><title>Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter‐structure in the aggregation response of human neutrophils</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>Human neutrophils aggregate after stimulation with various stimuli; this response is completely absent in neutrophils from patients with leukocyte adhesion defiency (LAD). To investigate the cellular requirements of this process a method was used in which neutrophils are separately loaded with hydroethidine (HE) and sulfofluorescein (SFDA), to give them either red fluorescence or green fluorescence. After mixing HE‐ and SFDA‐labeled cells in a ratio of 1 : 1, the number of double‐colored aggregates formed after activation was determined by analysis on a fluorescence‐activated cell sorter. In this way, essential information is obtained when cells of different origin are used. The formation of aggregates between neutrophils of an LAD patient and control neutrophils was thus quantified. Because neutrophil aggregation is dependent mostly on the presence of complement receptor type 3 (CR3), which is not present on LAD neutrophils, this result revealed the presence of a counter‐structure for CR3 on LAD neutrophils (and hence on normal human neutrophils). In addition to the presence of these proteins on the cell surface, aggregation required continuous cell triggering as indicated by the transient aggregation induced by short‐term activation of protein kinase C. This phenomenon was substantiated by the fact that energy depletion caused profound disaggregation. The present study reveals that neutrophil aggregation is a well‐controlled process, which needs constant activation of CR3 for a stable interaction with a constitutively expressed counter‐structure.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Antibodies, Monoclonal</subject><subject>Biological and medical sciences</subject><subject>Cations - pharmacology</subject><subject>Cell Adhesion Molecules - physiology</subject><subject>Cell Aggregation</subject><subject>Energy Metabolism</subject><subject>Flow Cytometry</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Inflammation</subject><subject>Iodoacetates - pharmacology</subject><subject>Iodoacetic Acid</subject><subject>Macrophage-1 Antigen</subject><subject>Molecular and cellular biology</subject><subject>Nephelometry and Turbidimetry</subject><subject>Neutrophils - physiology</subject><subject>Receptors, Complement - physiology</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi1EVZbClRuSD4hbtuPYSewjWhUoqsSlPUeOd7LrKrGD7VDtrY_Ac_BYPAmOdlW49TSH-eafmf8n5B2DNQMoL_HerpnkUAJwaF6QFatKVggm2EuyAmCiKJWEV-R1jPcAoOpKnZPzkkloSrEivzfeJetmP0dqcBioNsn-1Ml6R22kDg3GqMOB9j7QmHQ3ILUuYVi4zPieGj9OA47oEg0Zn1Im02FCyumDTXtqU5b28zL05_FXTGE2aQ6LDE17pHq3C7g7bgwYJ-8iLrL7edQuHzCn4Ke9HeIbctbrIeLbU70gd5-vbjdfi5vvX643n24KIwCaQgLnMj_ayIo3qtSG86art6Ku6uxMpbJNDPoeK1BSdHXdmy2wDlGbZssNAr8gH4-6U_A_ZoypHW1cvNEOs01to2olhKqeBVklGROlyuD6CJrgYwzYt1OwY3a1ZdAuKbY5xfZfinng_Ul57kbcPuGn2HL_w6mvo9FDH7QzNj5htRR1IxdMHbEHO-DhmaXt1bfr_074Cxs3ufU</recordid><startdate>199003</startdate><enddate>199003</enddate><creator>Kuypers, Taco W.</creator><creator>Koenderman, Leo</creator><creator>Weening, Ron S.</creator><creator>Verhoeven, Arthur J.</creator><creator>Roos, Dirk</creator><general>WILEY‐VCH Verlag GmbH</general><general>Wiley-VCH</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199003</creationdate><title>Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter‐structure in the aggregation response of human neutrophils</title><author>Kuypers, Taco W. ; Koenderman, Leo ; Weening, Ron S. ; Verhoeven, Arthur J. ; Roos, Dirk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4007-803380097853792ac337b6d46565215903010ffe50984b66fcd01beeac7d3ce03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Antibodies, Monoclonal</topic><topic>Biological and medical sciences</topic><topic>Cations - pharmacology</topic><topic>Cell Adhesion Molecules - physiology</topic><topic>Cell Aggregation</topic><topic>Energy Metabolism</topic><topic>Flow Cytometry</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Inflammation</topic><topic>Iodoacetates - pharmacology</topic><topic>Iodoacetic Acid</topic><topic>Macrophage-1 Antigen</topic><topic>Molecular and cellular biology</topic><topic>Nephelometry and Turbidimetry</topic><topic>Neutrophils - physiology</topic><topic>Receptors, Complement - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kuypers, Taco W.</creatorcontrib><creatorcontrib>Koenderman, Leo</creatorcontrib><creatorcontrib>Weening, Ron S.</creatorcontrib><creatorcontrib>Verhoeven, Arthur J.</creatorcontrib><creatorcontrib>Roos, Dirk</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kuypers, Taco W.</au><au>Koenderman, Leo</au><au>Weening, Ron S.</au><au>Verhoeven, Arthur J.</au><au>Roos, Dirk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter‐structure in the aggregation response of human neutrophils</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>1990-03</date><risdate>1990</risdate><volume>20</volume><issue>3</issue><spage>501</spage><epage>508</epage><pages>501-508</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><coden>EJIMAF</coden><abstract>Human neutrophils aggregate after stimulation with various stimuli; this response is completely absent in neutrophils from patients with leukocyte adhesion defiency (LAD). To investigate the cellular requirements of this process a method was used in which neutrophils are separately loaded with hydroethidine (HE) and sulfofluorescein (SFDA), to give them either red fluorescence or green fluorescence. After mixing HE‐ and SFDA‐labeled cells in a ratio of 1 : 1, the number of double‐colored aggregates formed after activation was determined by analysis on a fluorescence‐activated cell sorter. In this way, essential information is obtained when cells of different origin are used. The formation of aggregates between neutrophils of an LAD patient and control neutrophils was thus quantified. Because neutrophil aggregation is dependent mostly on the presence of complement receptor type 3 (CR3), which is not present on LAD neutrophils, this result revealed the presence of a counter‐structure for CR3 on LAD neutrophils (and hence on normal human neutrophils). In addition to the presence of these proteins on the cell surface, aggregation required continuous cell triggering as indicated by the transient aggregation induced by short‐term activation of protein kinase C. This phenomenon was substantiated by the fact that energy depletion caused profound disaggregation. The present study reveals that neutrophil aggregation is a well‐controlled process, which needs constant activation of CR3 for a stable interaction with a constitutively expressed counter‐structure.</abstract><cop>Weinheim</cop><pub>WILEY‐VCH Verlag GmbH</pub><pmid>2180724</pmid><doi>10.1002/eji.1830200307</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 1990-03, Vol.20 (3), p.501-508
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_79694495
source MEDLINE; Access via Wiley Online Library
subjects Adenosine Triphosphate - metabolism
Antibodies, Monoclonal
Biological and medical sciences
Cations - pharmacology
Cell Adhesion Molecules - physiology
Cell Aggregation
Energy Metabolism
Flow Cytometry
Fundamental and applied biological sciences. Psychology
Humans
In Vitro Techniques
Inflammation
Iodoacetates - pharmacology
Iodoacetic Acid
Macrophage-1 Antigen
Molecular and cellular biology
Nephelometry and Turbidimetry
Neutrophils - physiology
Receptors, Complement - physiology
title Continuous cell activation is necessary for stable interaction of complement receptor type 3 with its counter‐structure in the aggregation response of human neutrophils
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T00%3A38%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Continuous%20cell%20activation%20is%20necessary%20for%20stable%20interaction%20of%20complement%20receptor%20type%203%20with%20its%20counter%E2%80%90structure%20in%20the%20aggregation%20response%20of%20human%20neutrophils&rft.jtitle=European%20journal%20of%20immunology&rft.au=Kuypers,%20Taco%20W.&rft.date=1990-03&rft.volume=20&rft.issue=3&rft.spage=501&rft.epage=508&rft.pages=501-508&rft.issn=0014-2980&rft.eissn=1521-4141&rft.coden=EJIMAF&rft_id=info:doi/10.1002/eji.1830200307&rft_dat=%3Cproquest_cross%3E15811429%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15811429&rft_id=info:pmid/2180724&rfr_iscdi=true